SCHEDULE 13G: Alyeska Investment Group Discloses 9.27% Passive Stake in BiomX Inc.

Alyeska Investment Group, L.P., along with its affiliates, has reported a significant passive ownership stake of 9.27% in BiomX Inc., totaling 2,316,076 shares.

Summary

• Alyeska Investment Group, L.P., Alyeska Fund GP, LLC, and Anand Parekh have filed a Schedule 13G, disclosing beneficial ownership in BiomX Inc.
• The reporting persons collectively beneficially own 2,316,076 shares of BiomX Inc. Common Stock.
• This ownership represents 9.27% of BiomX Inc.'s outstanding Common Stock.
• The shares include 1,590,738 shares of Common Stock and Warrants convertible into 725,338 shares of Common Stock as of March 31, 2025.
• The percentage calculation is based on 24,996,053 outstanding shares of Common Stock, as reported by BiomX Inc. in its Form 8-K filed on March 3, 2025.
• The filing certifies that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing the control of BiomX Inc.

Sentiment

Score: 6

Explanation: The sentiment is moderately positive as a significant stake by a reputable investment group can signal confidence in the company, even if it's a passive investment. There are no negative implications within the filing itself.

Positives

• A significant stake (9.27%) by a notable investment group like Alyeska Investment Group could be interpreted as a vote of confidence in BiomX Inc.'s future prospects.
• The investment is stated to be for passive purposes, indicating no immediate intent to influence or change control of the issuer.

Future Outlook

NA

Industry Context

This filing indicates a significant investment by a hedge fund in a biotechnology company, which is common for funds seeking exposure to growth sectors. The passive nature of the investment suggests a belief in the company's long-term value without immediate activist intentions.

Stakeholder Impact

• Shareholders: The disclosure of a significant passive stake by an institutional investor may instill confidence and potentially attract further institutional interest, which could positively influence share price.
• Company Management: Awareness of a large passive shareholder may influence strategic decisions, though the filing explicitly states no intent to influence control.

Key Dates

Keywords

BiomX Inc., Alyeska Investment Group, Schedule 13G, Beneficial Ownership, Common Stock, Investment Group, Passive Investment, SEC Filing, Biotechnology, Healthcare